“A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S29. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/281.